Photo by nci from unsplash
e21071Background: Checkpoint inhibitors are widely used in NSCLC. While there is evidence that EGFR mutation driven tumours respond poorly to checkpoint inhibition, little is known about the sensit... Click to show full abstract
e21071Background: Checkpoint inhibitors are widely used in NSCLC. While there is evidence that EGFR mutation driven tumours respond poorly to checkpoint inhibition, little is known about the sensit...
Keywords:
response checkpoint;
inhibition lung;
checkpoint inhibition;
lung cancer;
checkpoint
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!